For the following health goals: Ingredients Each vegetable capsule Non-Medicinal Ingredients Dicalcium phosphate, hypromellose, magnesium stearate, microcrystalline cellulose, silicon dioxide
Exposure to GLP-1 RAs was consistently associated with significantly reduced odds of SUD cases
It activates two of the same three receptors (GLP-1 and GIP), missing only the glucagon pathway
15% Patients lost an average of 15% of their body weight in ~1 year.* *In a 68-week double-blind trial studying once-weekly semaglutide injections (2.4 mg) in 1,961 patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15%, when paired with diet and exercise changes
Typically, insurers only cover a medication when it is prescribed for an FDA-approved indication
The rise of GLP 1 weight loss drugs has transformed the landscape of chronic weight management